Article info
PDFCurrent controversy
Ethical argument for establishing good manufacturing practice for phage therapy in the UK
- Correspondence to Dr Mehrunisha Suleman, Nuffield Department of Population Health, University of Oxford, Oxford, UK; mehrunisha.suleman{at}ethox.ox.ac.uk
Citation
Ethical argument for establishing good manufacturing practice for phage therapy in the UK
Publication history
- Received July 12, 2023
- Accepted January 10, 2024
- First published February 11, 2024.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Other content recommended for you
- Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
- Standardised treatment and monitoring protocol to assess safety and tolerability of bacteriophage therapy for adult and paediatric patients (STAMP study): protocol for an open-label, single-arm trial
- Combating antimicrobial resistance: an evidence-based overview of bacteriophage therapy
- Phage therapy is highly effective against chronic lung infections with Pseudomonas aeruginosa
- Prescribing for children at the interfaces of care
- Substandard and falsified medicines in the UK: a retrospective review of drug alerts (2001–2011)
- Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy
- News and updates from palliativedrugs.com
- Gut virome in inflammatory bowel disease and beyond
- Inspectorate surveillance of preparing and distributing pharmacies in The Netherlands